Frontiers in immunology · 2021
The Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness: A German Multicenter Analysis.
СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mytilineos Daphne, Tsamadou Chrysanthi, Neuchel Christine, Platzbecker Uwe, Bunjes Donald, Schub Natalie, Wagner-Drouet Eva, Wulf Gerald, Kröger Nicolaus, Murawski Niels, Einsele Hermann, Schaefer-Eckart Kerstin, Freitag Sebastian, Casper Jochen, Kaufmann Martin, Dürholt Mareike, Hertenstein Bernd, Klein Stefan, Ringhoffer Mark, Mueller Carlheinz R, Frank Sandra, Schrezenmeier Hubert, Fuerst Daniel, Mytilineos Joannis
Аннотация
T-cell epitope matching according to the TCE3 algorithm classifies HLA-DPB1 mismatches in permissive and non-permissive. This classification has been shown to be predictive for mortality and acute GvHD (aGvHD) events in large international cohorts. We retrospectively genotyped HLA-DPB1 in 3523 patients transplanted in Germany between 2000 and 2014 and in their unrelated donors using an Illumina amplicon-NGS based assay. Aim of the study was to evaluate DP-compatibility beyond the established TCE3 algorithm by assessing the combined effect of several DP-mismatch parameters on post-transplant outcome. We implemented an extended DP-mismatch assessment model where TCE3, DP allotype expression with respect to rs9277534, mismatch vector and number of mismatches were conjointly taken into consideration. In this model, non-permissive HLA-DPB1 mismatches showed significantly increased aGvHD risk if they were accompanied by two HLA-DPB1 mismatches in GvH direction (HR: 1.46) or one mismatched highly expressed patient allotype (HR: 1.53). As previously reported, non-permissive HLA-DPB1 mismatches associated with a significantly higher risk of aGvHD and non-relapse mortality (HR 1.36 and 1.21, respectively), which in turn translated into worse GvHD and relapse free survival (HR 1.13). Effects on GvL and GvHD appeared strongest in GvH-directed non-permissive mismatches. Our study results support the consideration of additional HLA-DPB1 mismatch parameters along with the established TCE3 matching algorithm for refinement of future donor selection. In particular, our findings suggest that DP non-permissiveness associated with two HLA-DPB1 mismatches or at least on highly expressed mismatched patient allotype should be avoided.
Предметные рубрики MeSH
3' Untranslated RegionsAdolescentAdultAgedAllelesAllograftsBone Marrow TransplantationChildChild, PreschoolEpitopes, T-LymphocyteFemaleGermanyGraft vs Host DiseaseGraft vs Leukemia EffectHLA-DP beta-ChainsHistocompatibilityHistocompatibility TestingHumansIncidenceInfantInfant, NewbornKaplan-Meier EstimateLymphocyte DepletionMaleMiddle AgedModels, ImmunologicalPeripheral Blood Stem Cell TransplantationPolymorphism, Single NucleotideRetrospective StudiesRiskUnrelated DonorsYoung Adult